These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23015521)

  • 1. Automated production of plant-based vaccines and pharmaceuticals.
    Wirz H; Sauer-Budge AF; Briggs J; Sharpe A; Shu S; Sharon A
    J Lab Autom; 2012 Dec; 17(6):449-57. PubMed ID: 23015521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant-based vaccines: novel and low-cost possible route for Mediterranean innovative vaccination strategies.
    Aboul-Ata AA; Vitti A; Nuzzaci M; El-Attar AK; Piazzolla G; Tortorella C; Harandi AM; Olson O; Wright SA; Piazzolla P
    Adv Virus Res; 2014; 89():1-37. PubMed ID: 24751193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using transgenic plants and modified plant viruses for the development of treatments for human diseases.
    Loh HS; Green BJ; Yusibov V
    Curr Opin Virol; 2017 Oct; 26():81-89. PubMed ID: 28800551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study.
    Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D
    Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient expression systems for plant-derived biopharmaceuticals.
    Komarova TV; Baschieri S; Donini M; Marusic C; Benvenuto E; Dorokhov YL
    Expert Rev Vaccines; 2010 Aug; 9(8):859-76. PubMed ID: 20673010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-based pharmaceutical production in plants: an opportunity to reduce health problems in Africa.
    Bamogo PKA; Brugidou C; Sérémé D; Tiendrébéogo F; Djigma FW; Simpore J; Lacombe S
    Virol J; 2019 Dec; 16(1):167. PubMed ID: 31888686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New areas of plant-made pharmaceuticals.
    Hassan SW; Waheed MT; Lössl AG
    Expert Rev Vaccines; 2011 Feb; 10(2):151-3. PubMed ID: 21332263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of a dwarf phenotype with IBH1 may enable increased production of plant-made pharmaceuticals in plant factory conditions.
    Nagatoshi Y; Ikeda M; Kishi H; Hiratsu K; Muraguchi A; Ohme-Takagi M
    Plant Biotechnol J; 2016 Mar; 14(3):887-94. PubMed ID: 26190496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From gene to harvest: insights into upstream process development for the GMP production of a monoclonal antibody in transgenic tobacco plants.
    Sack M; Rademacher T; Spiegel H; Boes A; Hellwig S; Drossard J; Stoger E; Fischer R
    Plant Biotechnol J; 2015 Oct; 13(8):1094-105. PubMed ID: 26214282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-derived vaccines and other therapeutics produced in contained systems.
    Franconi R; Demurtas OC; Massa S
    Expert Rev Vaccines; 2010 Aug; 9(8):877-92. PubMed ID: 20673011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel and fully scalable Agrobacterium spray-based process for manufacturing cellulases and other cost-sensitive proteins in plants.
    Hahn S; Giritch A; Bartels D; Bortesi L; Gleba Y
    Plant Biotechnol J; 2015 Jun; 13(5):708-16. PubMed ID: 25470212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant glycans: friend or foe in vaccine development?
    Bosch D; Schots A
    Expert Rev Vaccines; 2010 Aug; 9(8):835-42. PubMed ID: 20673008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transgenic plants as a medicine production system].
    Okada Y
    Tanpakushitsu Kakusan Koso; 2000 Mar; 45(4):607-13. PubMed ID: 10714178
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel detection system for plant protein production of pharmaceuticals and impact on conformational diseases.
    Nagel KA; Kastenholz B; Gilmer F; Schurr U; Walter A
    Protein Pept Lett; 2010 Jun; 17(6):723-31. PubMed ID: 20015023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations.
    Lai H; Chen Q
    Plant Cell Rep; 2012 Mar; 31(3):573-84. PubMed ID: 22134876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of Physcomitrella patens as a platform for the production of plant-based vaccines.
    Rosales-Mendoza S; Orellana-Escobedo L; Romero-Maldonado A; Decker EL; Reski R
    Expert Rev Vaccines; 2014 Feb; 13(2):203-12. PubMed ID: 24405402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of plant expression systems in antibody production for passive immunization.
    Virdi V; Depicker A
    Int J Dev Biol; 2013; 57(6-8):587-93. PubMed ID: 24166441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on current downstream bio-processing technology of vaccine products.
    Li M; Qiu YX
    Vaccine; 2013 Feb; 31(9):1264-7. PubMed ID: 23313813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.